NOVO NORDISK A/S

Remarks in House

Pharmaceuticals: decision by manufacturers to cap patient out-of-pocket costs for insulin, H1535 [29MR]

Remarks in Senate

Pharmaceuticals: decision by manufacturers to cap patient out-of-pocket costs for insulin, S756 [14MR], S810 [16MR]